Clinical trial

IMPACT-HTN Study of Patients With Hypertension

NCT07579260

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2026-07-01

PhaseN/A

Study timeline

Study start (estimated)2026-07-01Date precision: day

Registry last updated2026-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension (HTN)unresolved

Hypertensionunresolved

Blood Pressure, Highunresolved

Interventions

Sponsors & collaborators

Vivek Bhallalead sponsor

Idorsia Pharmaceuticals Ltd.collaborator

Duke University Medical Center, Durham, NCcollaborator

Mapped research locations

DurhamNorth Carolina, United States1 Palo AltoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07579260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.